SLC39A10 and breast carcinoma: ZIP10 has also been connected to cancer progression as a marker of metastatic breast cancer [35], an indicator of aggressiveness of renal cell carcinoma [36] and associated with the expression of oestrogen receptor, ERBB3 and STAT3 in clinical breast cancer [34].